The benefits of the new generation bone sonometer
UltraScan 650 is the only FDA-approved ultrasound device designed to replace DXA for measuring bone mineral density (BMD)
at the 1/3 radius. It combines DXA‑equivalent accuracy with portability and workflow simplicity, making advanced bone assessment
accessible in everyday practice.
Accurate & reliable
- DXA-comparable performance: UltraScan 650 provides BMD values that correlate strongly with DXA
(r = 0.93) with a precision of approximately 2%.
- Clinically familiar reporting: Output includes BMD in g/cm², T-scores, and Z-scores in a format
similar to standard DXA reports, supporting confident diagnosis and management of osteoporosis.
- Validated technology: The system is built on CyberLogic’s patented Net Time Delay (NTD) technology,
supported by simulation, in vitro, and clinical data.
Fast & easy to use
- 10-second exam: A typical BMD assessment takes under 10 seconds, enabling high patient throughput.
- Simple patient positioning: Measurement at the forearm requires only that the patient roll up a sleeve;
the foot is not involved.
- No gel, no radiation: The exam is clean, comfortable, and free of ionizing radiation.
- Automated processing: The device does not require user interaction with data processing, reducing
operator variability and training burden.
Convenient for any practice
- Portable and lightweight: Weighing less than 8 pounds, UltraScan 650 is designed for easy transport
and flexible deployment.
- USB/battery powered: Operates with a user-supplied laptop and does not require a dedicated power outlet
or shielded room.
- Compact footprint: The desktop footprint (approximately 10 × 15 inches) fits comfortably in most
exam rooms or office environments.
- Streamlined reporting: Results can be printed or emailed immediately, with concise, easy-to-interpret
reports that support timely clinical decisions.